Mizuho vs Canaccord
Both are in NY and TMT. I’m aware these are smaller banks and aren’t near top 10 on the league table but which one will have a higher bonus/prestige?
Trending Content - Investment Banking Forum
| +183 | Evercore > Goldman and I don’t think it’s particularly close anymore | 65 | 6h |
| +157 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 17 | 1d |
| +87 | UBS Offer Day | 30 | 1d |
| +86 | Santander IB? | 10 | 3d |
| +71 | I hate Wells Fargo | 19 | 1d |
| +67 | Think Twice before Recruiting for HOUSTON IB!! | 36 | 1h |
| +51 | No return offer - feeling like a failure is an understatement | 20 | 19h |
| +49 | How cooked am I as an incoming WF IB SA 2027? | 17 | 21h |
| +46 | WF Return offers | 28 | 2d |
| +40 | 2026 Investment Banking Return Offer Climate | 25 | 1d |
Career Resources
is this for SA?
No full time analyst
Mizuho and its not even close.
Either you don't work in banking or you're very misinformed. I work at a top MM and in terms of M&A or TMT, I would take Canaccord over Mizuho. Canaccord's deal sizes tend to be in the 100m-500m range with occasional deals in the 1-2b range, but the firm has decent deal flow in terms of tech M&A and TMT ECM. I have a buddy at Mizuho who's been trying to lateral for over 6 months now. According to him, he's not had the chance to work on any M&A deals in the past 2 years. As others have mentioned, Mizuho tends to primarily do debt deals.
I help run the lateral recruitment process for my group, and we would rather hire candidates with decent middle-market M&A experience over candidates with debt-focused deal experience. Although Canaccord is certainly not a sexy brand name, the experience itself is likely much better than the experience at Mizuho.
I second this. Currently having trouble lateraling as well. On junior level, type of work you do matters so much more than deal size
Completely disagree also I’m pretty sure it’s cgc petsky prunier after the merger. Mizuho recruits heavily at my school and I have several friends there. I can promise you one thing you will never see an M&A deal at Mizuho it is purely a dcm/corporate banking role. This is regardless of group. cgc might not be the sexiest name either but I know for a fact that they actually offer real advisory and you would be able to get some kind of mm deal experience.
.
I know Mizuho used to be predominantly debt but I’ve been told within the last 3 years they’ve been ramping up M&A. Typically if you’re staffed on let’s say 6 deals, what is the breakdown between M&A, DCM, ECM?
100% debt
according to the dealogic league tables they havent done a single US M&A deal LTM lol
first thought when hearing canaccord was that it was a rare brazilian bird species. Since ive been on this forum for 2+ years and never heard of the firm lol
For Mizuho, you should know that this year bonuses were way below the street. People were furious because bank had a really good year. Mass exit from TMT group recently including an MD. Having said that, TMT is one of the best groups in the bank, more deal flow than most groups. Very active in IPOs but not many advisory M&A. Overall, the bank is aggressively pushing towards M&A. It could be a solid M&A place in the future but not this year
I thought first year analyst bonus was 40k, when stubbed for 9/12 months that comes out to 53.3k. Isn’t that street?
This is a European perspective, but hopefully still applies.
Prestige: Mizuho is a "lower tier" balance sheet bank. It sits beneath Nomura, HSBC and BNP, alongside and below the INGs and others of this world. CG is a little known boutique to many inside, let alone outside of finance. Therefore, Mizuho is the more prestigious in the traditional sense due to greater establishment with no meaningful differences in selectivity.
Comp: no 1st hand knowledge of either but intuitively both will be weak. Japanese banks are notorious weak payers for sure. Nomura underpay vs. other balance sheet banks even. CG has its own problems and have heard in Europe that bonuses were very weak and thats if you kept your job after the last cycle.
In total, I would decide on other factors than the two above. Like whether you want particularly verticals or specific exits and look from that perspective. For pure banking prestige and lateral potential to better banks, I'd got Mizuho. If you want to go to VC and cover cannabis or something funky and entrepreneurial maybe CG?
Never interacted with Mizuho, but see a ton of deals from CG on the tech side and everyone I’ve ever spoken to there has been friendly and smart. They get some cool mandates and are very active - have their latest update in my inbox and they closed 90 transactions LTM Q1 ‘21.
This ^^^^
Mizuho most likely won't give you M&A reps which will prove to be a problem if you try and lateral in the future despite the large platform and better known brand overall.
Basically. This person said it best if you want to do M&A don't go to Mizuho. Plain & simple lol.
Guess another relevant question is if either has seen Comp Increases since the GS 13?
Hope you went CG lmao
Canaccord all the way in. That firm is growing fast, pretty much leaders on the independent space in Canada. They also jump into many of the sectors that bigger banks find to risky (I.e. were the first ones doing Cannabis years ago, Bitcoin/blockchain).
CG 100%. Tech at CG is the real deal as they pretty much mass produce MM deals (no pun intended) in both M&A and equity financing. In the US, base increased to $100k.
Bump - any updates?
Seeing as Cannacord paid their Associates something ridiculous like half a million, for FY 2021, I think everyone who threw their vote in that direction has been vindicated lol
Still voting mizuho on this one
Bump. Is CG actually paying insanely well with good WLB? Why I have never heard about this firm yet they have a good MM TMT practice
Qui eos sint rerum deserunt dicta possimus numquam. Ducimus velit vel adipisci voluptas accusamus. Optio doloremque porro omnis qui aliquid esse officia. Consequatur delectus corrupti consectetur non voluptate ad inventore. Quisquam excepturi consectetur dolor et et dolor. Optio modi fugit minima iusto rerum autem.
Sint expedita esse debitis tempora quam deleniti. Beatae dolores in ex saepe et aut. Accusamus exercitationem veniam corporis ab.
Dicta ipsum perspiciatis aut voluptatibus quia. Repellendus nisi quis dolor quas mollitia fugit incidunt. Earum ipsum rerum deserunt ipsum suscipit. Porro nisi ullam non ducimus nostrum.
Exercitationem aperiam blanditiis voluptatem voluptates. Non non natus nam quas totam repellat. Ut cum et aperiam tempora. Dicta laudantium repudiandae ipsa sunt. Modi ut explicabo esse repellat corporis adipisci nostrum laboriosam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Necessitatibus aperiam voluptatem corporis sed qui. Magnam quis dignissimos modi alias modi cupiditate. Voluptatem consectetur doloribus dolores fugiat. Corrupti voluptatum aut autem laudantium quia sequi. Quos deserunt commodi qui amet molestias perferendis neque. Excepturi eaque qui ut occaecati. Iusto facilis in deserunt dolores exercitationem.